HERTAB 250MG(BREAST CANCER)
DESCRIPTION
Hertab 250mg belongs to class of antineoplastic drugs which prevents the development and spreading of cancer cells all over the body.Hertab 250mg tablet is indicated for metastatic breast cancer and spreading after using of other chemotherapy drugs
 |
HERTAB 250MG |
INDICATION
Hertab 250mg with combination of capecitabine is indicated for the treatment of advanced breast cancer after the failure of other cancer medicine.Hertab 250mg is also combined with letrozole is indicated for the treatment postmenopausal women with hormone receptor positive metastatic breast cancer.
MECHANISM OF ACTION
Hertab 250mg tablet is a type of classification called kinase inhibitor and act by intracellular tyrosine kinase.Hertab 250mg prohibits ErbB-forced tumor cell growth in vitro and in various animal models. When combination 5-fluracil with Hertab 250mg created an additive effect in the 4 tumor cell lines tested. Development inhibitsthe Hertab tablet effect wereexamined in trastuzumab-conditioned cell lines.
Hertab 250mg tablet provide selective action against breast cancer cell lines selected for long-term growth in trastuzumab-containing intracellularly. Hormone receptor-positiveHertab 250mg tablet breast cancer cells (with ER [Estrogen Receptor] and/or PgR [Progesterone Receptor]) that co express the HER2 bear to be protection against established endocrine therapies. Synchronously hormone receptor-positive breast cancer cells that initially lack EGFR or HER2 unrecalled these receptor proteins as the tumor becomes resistant to endocrine therapy.
PRODUCT DETAILS:
Brand : HertabIngredients : Lapatinib
Strength : 250 mg
Manufactured : Hetero Healthcare
Package : 150 Tablets
DOSAGE MANAGEMENT
The usual dose of Hertab 250mg for adultsuffering HER2 positive metastatic breast cancer (with Xeloda) is 1250mg once daily for 1-21days continuously repeating.FemoraCombination withHertab the dose recommended is 1500mg orally Hertab 250mg tablet once a day continuously once daily every day.
Take the drug Hertab 250mg tablet on an empty stomach (1hr before or 1hr after).
OVERDOSE:
If overdose occurs, seek to emergency department or call poison control helpline
If you had hepatic problem,Hertab 250mg tablet cardio disease, an electrolytic imbalance then discusses with doctor whether it’s safe to use or not prior to Hertab 250mg treatment.
While patients during pregnancy, it should strictly avoid the drug because it harms the unborn baby or cause birth defects.
There is not known whether Lapatinib passes into breast milk. Hence avoid breast feeding to the infants duringHertab treatment,
PRECAUTIONS
If you are allergic to lapatinib, then do not use the drugIf you had hepatic problem,Hertab 250mg tablet cardio disease, an electrolytic imbalance then discusses with doctor whether it’s safe to use or not prior to Hertab 250mg treatment.
While patients during pregnancy, it should strictly avoid the drug because it harms the unborn baby or cause birth defects.
There is not known whether Lapatinib passes into breast milk. Hence avoid breast feeding to the infants duringHertab treatment,
SIDE EFFECT
Hertab 250mg will cause mild to moderate side effects in patients. If symptoms cause serious the inform the doctor as soon as possible.Common side effect of Hertab 250mg tablets:
Lumbar pain; diarrhae; dry skin; nail of finger toe changes; headache; in digestion problem ; decreased appetite; mild hair loss or thinning; mouth ulcers; nausea; nosebleed; redness and hands and feet will have tingling; weakness; insomnia; vomiting.Serious side effect of Hertab 250mg tablets :
Severe tightness; difficulty in breathing; unusual bruising or bleeding; unusual itching; yellowing of the eyes or skin; Chest pain; urine will be dark; Hertab 250mg tablet dizziness or light-headedness; Rapid or irregular heartbeat; pale stools; persistent loss of appetite; severe or persistent cough; severe or persistent diarrhea, Hertab 250mg tablet nausea, vomiting and skin allergy like itching, rashes, blisters in mouth,face,lip or tongue.EMAIL ID : millionhealthpharmaceuticals@gmail.com
PHONE NO : +91-9940472902
No comments:
Post a Comment